Baumgartner H, Ritsch R, Luz O, Schneeberger J, Hammerer I
Institut für Biochemische Pharmakologie, Universität Innsbruck, Austria.
Pediatr Res. 1992 Jun;31(6):579-82. doi: 10.1203/00006450-199206000-00008.
In this study, we investigated whether capillary plasma catecholamines can be used as a suitable substitute for arterial catecholamines. Analysis was done radioenzymatically. Catecholamine concentrations were not different in arterial and simultaneously collected "arterialized" (warmed foot) capillary plasma obtained by heel-prick from 18 neonatal intensive care patients as assessed by linear regression analysis (correlation coefficient: 0.966 for noradrenaline; 0.894 for adrenaline; p less than 0.05) and by a Wilcoxon test [noradrenaline: 2.13 (0.61-10.47) versus 2.41 (1.05-10.23); adrenaline: 0.75 (0.16-1.70) versus 0.72 (0.10-1.37) nmol/L, median (range)]. However, "arterialization" of capillary blood is important; when blood was obtained in nine neonates without warming their feet, capillary concentrations of noradrenaline were higher than arterial values (p less than 0.03) and those of adrenaline were not different from arterial values. Catecholamine concentrations in arterialized capillary plasma collected in healthy full-term infants at 1 h [n = 9; noradrenaline: 6.85 (3.09-8.88) nmol/L; adrenaline: 1.34 (0.86-2.85) nmol/L] and 5 d after birth [n = 27; noradrenaline: 1.58 (0.89-3.16) nmol/L; adrenaline: 0.59 (0.25-1.64) nmol/L] reflect the well-known fall (p less than 0.01) in catecholamine levels after delivery. With a highly sensitive analytical technique, catecholamine concentrations can reliably be assessed in minute samples (100-200 microL) of arterialized capillary blood, even when concentrations have dropped to low "resting" basal levels. Moreover, the capillary sampling procedure is simple and safe, can easily be applied to healthy infants, and does not have the practical and ethical limitations of arterial blood sampling.
在本研究中,我们调查了毛细血管血浆儿茶酚胺是否可作为动脉儿茶酚胺的合适替代物。采用放射酶法进行分析。通过足跟采血从18名新生儿重症监护患者同时采集的动脉血和“动脉化”(足部加温)毛细血管血浆中的儿茶酚胺浓度,经线性回归分析(去甲肾上腺素的相关系数:0.966;肾上腺素的相关系数:0.894;p<0.05)和Wilcoxon检验评估无差异[去甲肾上腺素:2.13(0.61 - 10.47)对2.41(1.05 - 10.23);肾上腺素:0.75(0.16 - 1.70)对0.72(0.10 - 1.37)nmol/L,中位数(范围)]。然而,毛细血管血的“动脉化”很重要;当在9名未加温足部的新生儿中采血时,去甲肾上腺素的毛细血管浓度高于动脉值(p<0.03),而肾上腺素的浓度与动脉值无差异。健康足月儿出生后1小时[n = 9;去甲肾上腺素:6.85(3.09 - 8.88)nmol/L;肾上腺素:1.34(0.86 - 2.85)nmol/L]和5天[n = 27;去甲肾上腺素:1.58(0.89 - 3.16)nmol/L;肾上腺素:0.59(0.25 - 1.64)nmol/L]采集的动脉化毛细血管血浆中的儿茶酚胺浓度反映了分娩后儿茶酚胺水平的显著下降(p<0.01)。使用高灵敏度分析技术,即使儿茶酚胺浓度已降至低“静息”基础水平,也能可靠地评估动脉化毛细血管血微量样本(100 - 200微升)中的儿茶酚胺浓度。此外,毛细血管采样程序简单安全,可轻松应用于健康婴儿,且不存在动脉采血的实际和伦理限制。